- Y Diweddaraf sydd Ar Gael (Diwygiedig)
- Pwynt Penodol mewn Amser (13/04/2011)
- Gwreiddiol (Fel y’i mabwysiadwyd gan yr UE)
Commission Directive 2004/33/EC of 22 March 2004 implementing Directive 2002/98/EC of the European Parliament and of the Council as regards certain technical requirements for blood and blood components (Text with EEA relevance)
When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.
Mae unrhyw newidiadau sydd wedi cael eu gwneud yn barod gan y tîm yn ymddangos yn y cynnwys a chyfeirir atynt gydag anodiadau.Ar ôl y diwrnod ymadael bydd tair fersiwn o’r ddeddfwriaeth yma i’w gwirio at ddibenion gwahanol. Y fersiwn legislation.gov.uk yw’r fersiwn sy’n weithredol yn y Deyrnas Unedig. Y Fersiwn UE sydd ar EUR-lex ar hyn o bryd yw’r fersiwn sy’n weithredol yn yr UE h.y. efallai y bydd arnoch angen y fersiwn hon os byddwch yn gweithredu busnes yn yr UE. EUR-Lex Y fersiwn yn yr archif ar y we yw’r fersiwn swyddogol o’r ddeddfwriaeth fel yr oedd ar y diwrnod ymadael cyn cael ei chyhoeddi ar legislation.gov.uk ac unrhyw newidiadau ac effeithiau a weithredwyd yn y Deyrnas Unedig wedyn. Mae’r archif ar y we hefyd yn cynnwys cyfraith achos a ffurfiau mewn ieithoedd eraill o EUR-Lex. The EU Exit Web Archive legislation_originated_from_EU_p3
EU Directives are published on this site to aid cross referencing from UK legislation. Since IP completion day (31 December 2020 11.00 p.m.) no amendments have been applied to this version.
Article 5.Storage, transport and distribution conditions for blood and blood components
Article 6.Quality and safety requirements for blood and blood components
1. ‘Autologous donation’ means blood and blood components collected from an...
2. ‘Allogeneic donation’ means blood and blood components collected from an...
3. ‘Validation’ means the establishment of documented and objective evidence that...
5. ‘Cryopreservation’ means prolongation of the storage life of blood components...
6. ‘Plasma’ means the liquid portion of the blood in which...
7. ‘Cryoprecipitate’ means a plasma component prepared from plasma, fresh-frozen, by...
8. ‘Washed’ means a process of removing plasma or storage medium...
10. ‘Red cells, buffy coat removed’ means the red cells from...
11. ‘Red cells, leucocyte-depleted’ means the red cells from a single...
12. ‘Red cells in additive solution’ means the red cells from...
13. ‘Additive solution’ means a solution specifically formulated to maintain beneficial...
14. ‘Red cells, buffy coat removed, in additive solution’ means the...
15. ‘Buffy coat’ means a blood component prepared by centrifugation of...
16. ‘Red cells, leucocyte-depleted, in additive solution’ means the red cells...
17. ‘Red cells, apheresis’ means the red cells from an apheresis...
18. ‘Apheresis’ means a method of obtaining one or more blood...
19. ‘Platelets, apheresis’ means a concentrated suspension of blood platelets obtained...
21. ‘Platelets, recovered, pooled’ means a concentrated suspension of blood platelets,...
22. ‘Platelets, recovered, pooled, leucocyte-depleted’ means a concentrated suspension of blood...
23. ‘Platelets, recovered, single unit’ means a concentrated suspension of blood...
24. ‘Platelets, recovered, single unit, leucocyte-depleted’ means a concentrated suspension of...
25. ‘Plasma, fresh-frozen’ means the supernatant plasma separated from a whole...
26. ‘Plasma, cryoprecipitate-depleted for transfusion’ means a plasma component prepared from...
27. ‘Granulocytes, apheresis’ means a concentrated suspension of granulocytes obtained by...
28. ‘Statistical process control’ means a method of quality control of...
PART A Information to be provided to prospective donors of blood or blood components
1. Accurate educational materials, which are understandable for members of the...
2. For both allogeneic and autologous donations, the reasons for requiring...
3. Information on the protection of personal data: no unauthorised disclosure...
4. The reasons why individuals are not to make donations which...
5. Specific information on the nature of the procedures involved either...
6. Information on the option for donors to change their mind...
7. The reasons why it is important that donors inform the...
8. Information on the responsibility of the blood establishment to inform...
9. Information why unused autologous blood and blood components will be...
10. Information that test results detecting markers for viruses, such as...
11. Information on the opportunity for donors to ask questions at...
PART B Information to be obtained from donors by blood establishments at every donation
ELIGIBILITY CRITERIA FOR DONORS OF WHOLE BLOOD AND BLOOD COMPONENTS
STORAGE, TRANSPORT AND DISTRIBUTION CONDITIONS FOR BLOOD AND BLOOD COMPONENTS
QUALITY AND SAFETY REQUIREMENTS FOR BLOOD AND BLOOD COMPONENTS
2. QUALITY CONTROL REQUIREMENTS FOR BLOOD AND BLOOD COMPONENTS
2.1. Blood and blood components must comply with the following technical...
2.2. Appropriate bacteriological control of the collection and manufacturing process must...
2.3. Member States must take all necessary measures to ensure that...
2.4. For autologous donations, the measures marked with an asterisk (*)...
Y Diweddaraf sydd Ar Gael (diwygiedig):Y fersiwn ddiweddaraf sydd ar gael o’r ddeddfwriaeth yn cynnwys newidiadau a wnaed gan ddeddfwriaeth ddilynol ac wedi eu gweithredu gan ein tîm golygyddol. Gellir gweld y newidiadau nad ydym wedi eu gweithredu i’r testun eto yn yr ardal ‘Newidiadau i Ddeddfwriaeth’.
Gwreiddiol (Fel y’i mabwysiadwyd gan yr UE): Mae'r wreiddiol version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.
Pwynt Penodol mewn Amser: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.
Gallwch wneud defnydd o ddogfennau atodol hanfodol a gwybodaeth ar gyfer yr eitem ddeddfwriaeth o’r tab hwn. Yn ddibynnol ar yr eitem ddeddfwriaeth sydd i’w gweld, gallai hyn gynnwys:
Mae’r llinell amser yma yn dangos y fersiynau gwahanol a gymerwyd o EUR-Lex yn ogystal ag unrhyw fersiynau dilynol a grëwyd ar ôl y diwrnod ymadael o ganlyniad i newidiadau a wnaed gan ddeddfwriaeth y Deyrnas Unedig.
Cymerir dyddiadau fersiynau’r UE o ddyddiadau’r dogfennau ar EUR-Lex ac efallai na fyddant yn cyfateb â’r adeg pan ddaeth y newidiadau i rym ar gyfer y ddogfen.
Ar gyfer unrhyw fersiynau a grëwyd ar ôl y diwrnod ymadael o ganlyniad i newidiadau a wnaed gan ddeddfwriaeth y Deyrnas Unedig, bydd y dyddiad yn cyd-fynd â’r dyddiad cynharaf y daeth y newid (e.e. ychwanegiad, diddymiad neu gyfnewidiad) a weithredwyd i rym. Am ragor o wybodaeth gweler ein canllaw i ddeddfwriaeth ddiwygiedig ar Ddeall Deddfwriaeth.
Defnyddiwch y ddewislen hon i agor dogfennau hanfodol sy’n cyd-fynd â’r ddeddfwriaeth a gwybodaeth am yr eitem hon o ddeddfwriaeth. Gan ddibynnu ar yr eitem o ddeddfwriaeth sy’n cael ei gweld gall hyn gynnwys:
liciwch ‘Gweld Mwy’ neu ddewis ‘Rhagor o Adnoddau’ am wybodaeth ychwanegol gan gynnwys